These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24739235)

  • 1. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S; Crow G;
    BMC Cancer; 2014 Apr; 14():263. PubMed ID: 24739235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
    BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve repeat fecal occult blood testing cancer screening.
    Davis TC; Arnold CL; Bennett CL; Wolf MS; Reynolds C; Liu D; Rademaker A
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):134-43. PubMed ID: 24192009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial incentives for completion of fecal occult blood tests among veterans: a 2-stage, pragmatic, cluster, randomized, controlled trial.
    Kullgren JT; Dicks TN; Fu X; Richardson D; Tzanis GL; Tobi M; Marcus SC
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S35-43. PubMed ID: 25402401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
    Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
    J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated telephone calls improved completion of fecal occult blood testing.
    Mosen DM; Feldstein AC; Perrin N; Rosales AG; Smith DH; Liles EG; Schneider JL; Lafata JE; Myers RE; Kositch M; Hickey T; Glasgow RE
    Med Care; 2010 Jul; 48(7):604-10. PubMed ID: 20508529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit.
    Davis TC; Arnold CL; Rademaker AW; Platt DJ; Esparza J; Liu D; Wolf MS
    J Rural Health; 2012; 28(3):306-11. PubMed ID: 22757955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.
    Lobchuk MM; Bapuji SB; McClement SE; Sisler JJ; Katz A; Martens P; Turner D; Clouston K
    Cancer Epidemiol; 2012 Jun; 36(3):e190-9. PubMed ID: 22310235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.
    Sewitch MJ; Jiang M; Grad R; Yaffe M; Pavilanis A; Joseph L; Barkun AN; Roper M
    Can Fam Physician; 2013 Dec; 59(12):e550-7. PubMed ID: 24336560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
    Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
    Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.